Study of ABT-700 in Subjects With Advanced Solid Tumors

NCT01472016 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: ABT-700
DRUG: docetaxel
DRUG: FOLFIRI
DRUG: cetuximab
DRUG: erlotinib
DRUG: ABT-700

Sponsor

AbbVie (prior sponsor, Abbott)